🇺🇸 FDA
Patent

US 11623012

Bicyclic peptide ligands specific for EphA2

granted A61KA61K47/64A61K47/6415

Quick answer

US patent 11623012 (Bicyclic peptide ligands specific for EphA2) held by BicycleRD Limited expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleRD Limited
Grant date
Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K47/64, A61K47/6415